Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Jan 19, 2021 48.10 -2.24   
 24Storage 24STOR Jan 19, 2021 41.20 -0.72   
 2cureX 2CUREX Jan 19, 2021 19.55 +0.51   
 A3 Allmänna IT- och Telekomaktiebolaget ATRE Jan 19, 2021 18.80 0.00   
 AAC Clyde Space AAC Jan 19, 2021 4.00 0.00   
 AAK AAK Jan 19, 2021 160.25 -2.05   
 ABB ABB Jan 19, 2021 245.90 -0.32   
 Abelco Investment Group ABIG Jan 19, 2021 0.12 +7.34   
 ABG Sundal Collier Holding ASCO Jan 19, 2021 5.74 0.00   
 Abliva ABLI Jan 19, 2021 0.76 -2.32   
 Absolent Group ABSO Jan 19, 2021 410.00 +2.50   
 Absolicon ABSL Jan 19, 2021 128.50 -0.39   
 AcadeMedia ACAD Jan 19, 2021 79.00 -2.23   
 Acarix ACARIX Jan 19, 2021 1.36 -1.81   
 Acconeer ACCON Jan 19, 2021 29.15 -3.32   
 Acosense ACOS Jan 19, 2021 1.40 -12.23   
 AcouSort ACOU Jan 19, 2021 24.50 -3.92   
 Acrinova ACRI Jan 19, 2021 19.20 -1.54   
 ACROUD ACROUD Jan 19, 2021 2.87 -0.35   
 Actic Group ATIC Jan 19, 2021 17.80 +1.42   
 Active Biotech ACTI Jan 19, 2021 1.80 +2.04   
 AcuCort ACUC Jan 19, 2021 4.83 -1.02   
 Adapteo ADAPT Jan 19, 2021 98.00 +1.24   
 AdderaCare ADDERA Jan 19, 2021 4.42 -2.64   
 AddLife B ALIFB Jan 19, 2021 148.60 0.00   
 Addnode Group B ANODB Jan 19, 2021 270.00 +0.19   
 Addtech B ADDTB Jan 19, 2021 117.00 -0.85   
 ADDvise Group A ADDVA Jan 19, 2021 1.90 -2.56   
 ADDvise Group B ADDVB Jan 19, 2021 1.52 +2.01   
 Adevinta ADEO Jan 19, 2021 124.70 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK